Study of the Activity of Indicators of Systemic Inflammation and Surfactant Protein D in Chronic Obstructive Pulmonary Disease, their Relationship with the Nutritional Status of Patients
Studying the levels of biomarkers of inflammation and surfactant protein D (SDP) in the peripheral blood of patients with chronic obstructive pulmonary disease (COPD) depending on the nutritional status (NS) of patients is relevant, since they are important factors in the progression of the disease.
Aim. To study the relationship between tumor necrosis factor-α (TNF-α), transforming growth factor β1 (TGFβ1), C-reactive protein (CRP), surfactant protein D (SPD) and NS in patients with COPD.
Materials and methods. 210 patients with COPD with different body mass index (BMI) were examined. Laboratory, instrumental (spirography, bioimpedansometry, pulse oximetry), spectrophotometric and immunoenzyme research methods were used.
Results. It is shown that in patients with COPD during an exacerbation of the disease, regardless of NS, there is an increase in the levels of TNFα, TGFβ1, CRP, as well as SDP in the blood serum, which is most pronounced when COPD is combined with obesity. A moderate correlation has been established between the level of SDP in the blood serum and the duration of smoking, as well as between SDP and BMI in patients with COPD; a negative correlation has been established between the level of SDP and indicators of external respiratory function.
Conclusion. The degree of increase in serum levels of TNF-α, TGFβ1 and CRP directly correlates with concomitant obesity in patients with COPD. The level of SDP in COPD depends on the patient’s NS and can serve as a diagnostic marker of the disease. Multivariate analysis confirms the dependence of the level of SDP in the blood serum on the parameters of bioimpedance analysis in COPD.
Efremova O.A., Blagov A.Yu., Fentisov V.V., Obolonkova N.I., Dubrova V.A., Balinyan D.B. 2024. Study of the Activity of Indicators of Systemic Inflammation and Surfactant Protein D in Chronic Obstructive Pulmonary Disease, their Relationship with the Nutritional Status of Patients. Challenges in Modern Medicine, 47(1): 27–40 (in Russian). DOI: 10.52575/2687-0940-2024-47-1-27-40
While nobody left any comments to this publication.
You can be first.
Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K., Smirnova M.I., Antsiferova A.A., Lukyanov M.M., Myrzamatova A.O., Mokhovikov G.I., Khudyakov M.B., Avdeev S.N. 2022. Forecast of the Socio-Economic Burden of Chronic Obstructive Pulmonary Disease in the Russian Federation in 2022. Pulmonology (in Russian). 32(4): 507–516. doi: 10.18093/0869-0189-2022-32-4-507-516
Efimenko E.V., Efremova O.A., Khodosh E.M. 2016. Diagnostic Features for probabilistic Risk Assessment of Exacerbations of Chronic Obstructive Pulmonary Disease. Scientific Bulletins of Belgorod State University. Series: Medicine. Pharmacy (in Russian). 5(226): 15–20.
Efremova O.A., Kamyshnikova L.A., Shelyakina E.V. Shkileva I.Yu., Khodosh E.M. 2016. The Role of Chronic Obstructive Pulmonary Disease in the Development of Multimorbid Pathology. Scientific Result. Medicine and Pharmacy (in Russian). 2(4): 13–18.
Clinical guidelines “Obesity” 2020 (17.02.2021) – Approved by the Ministry of Health of the Russian Federation (in Russian). Available at: http://disuria.ru/_ld/9/990_kr20E66mz.pdf (accessed: 05.12.2023)
Clinical recommendations «Chronic obstructive pulmonary disease» of the Russian Respiratory Society and the Russian public organization «Russian Scientific Medical Society of Therapists» 2023 (in Russian). Available at: https://spulmo.ru/upload/kr/HOBL_2023_draft.pdf (accessed: 15.01.2024)
Romantsova TI. 2021. Adipose Tissue: Colors, Depots and Functions. Obesity and Metabolism. 18(3): 282–301 (in Russian). doi: https://doi.org/10.14341/omet12748
Tashmetova G.T. 2022. The Importance of Cytokines in the Progression of Chronic Obstructive Pulmonary Disease. Central Asian Research Journal for Interdisciplinary Studies (CARJIS). 2(2): 232–241 (in Russian). doi: 10.24412/2181-2454-2022-2-232-241
Shchepikhin E.I., Shmelev E.I., Zaitseva A.S. 2022. Respiratory Diseases and Obesity: Distinct Phenotype or Independent Events. Therapeutic Archive. 94(3): 442–447 (in Russian). doi:10.26442/00403660.2022.03.201412
Uryasev O.M., Panfilov Yu.A., Granatkin M.A., Pyko A.A. 2020. Comorbid Pathology in Chronic Obstructive Pulmonary Disease. Bulletin of Volgograd State Medical University. 2 (74): 174–177 (in Russian).
Almagro P., Soler-Cataluña J.J., Huerta A., González-Segura D., Cosío B.G. 2024. CLAVE Study Investigators. Impact of Comorbidities in COPD Clinical Control Criteria. The CLAVE Study. BMC Pulm Med. 24(1): 6. doi: 10.1186/s12890-023-02758-0
Alqarni A.A., Badr O.I., Aldhahir A.M., Alqahtani J.S., Siraj R.A., Naser A.Y., Alghamdi A.S., Majrshi M., Alghamdi S.M., Alyami M.M., Alghamdi S.A., Alwafi H. 2024. Obesity Prevalence and Association with Spirometry Profiles, ICU Admission, and Comorbidities Among Patients with COPD: Retrospective Study in Two Tertiary Centres in Saudi Arabia. Int. J. Chron. Obstruct. Pulmon. Dis. 2024 Jan 16;19: 111–120. doi: 10.2147/COPD.S442851
Аgustí A., Celli B.R., Criner G.J., Halpin D., Anzueto A., Barnes P., Bourbeau J., Han M.K., Martinez F.J., de Oca M.M., Mortimer K., Papi A., Pavord I., Roche N., Salvi S., Sin D.D., Singh D., Stockley R., Victorina M., Varela L., Wedzicha J.A., Vogelmeier C.F. 2023. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur. Respir. J. Mar 3:2300239. doi: 10.1183/13993003.00239-2023
Au D.H., Gleason E., Hunter-Merrill R., Barón A.E., Collins M., Ronneberg C., Lv N., Rise P., Wai T.H., Plumley R., Wisniewski S.R., Sciurba F.C., Kim D.Y., Simonelli P., Krishnan J.A., Wendt C.H., Feemster L.C., Criner G.J., Maddipati V., Mohan A., Ma J. 2023. Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical Trial. Ann. Am. Thorac. Soc. 20(12): 1743–1751. doi: 10.1513/AnnalsATS.202305-458OC.
Cheng X., Jiang S., Pan B., Xie W., Meng J. Ectopic and Visceral Fat Deposition in Aging, Obesity, and Idiopathic Pulmonary Fibrosis: an Interconnected Role. Lipids Health Dis. 2023 Nov 24;22(1): 201. doi: 10.1186/s12944-023-01964-3
Christenson S.A., Smith B.M., Bafadhel M., Putcha N. 2022. Chronic Obstructive Pulmonary Disease. Lancet. Jun 11;399(10342): 2227–2242. doi: 10.1016/S0140-6736(22)00470-6
Ellulu M.S., Patimah I., Khaza'ai H., Rahmat A., Abed Y. 2017. Obesity and Inflammation: the Linking Mechanism and the Complications. Arch. Med. Sci. 13(4): 851–863. doi: 10.5114/aoms.2016.58928
Hinata D., Fukuda R., Okiyoneda T. 2023. The COPD-Associated Polymorphism Impairs the CFTR Function to Suppress Excessive IL-8 Production upon Environmental Pathogen Exposure. Int. J. Mol. Sci. 24(3): 2305. doi:10.3390/ijms24032305
Hristova V.A., Watson A., Chaerkady R., Glover M.S., Ackland J., Angerman B., Belfield G., Belvisi M.G., Burke H., Cellura D., Clark H.W., Etal D., Freeman A., Heinson A.I., Hess S., Hühn M., Hall E., Mackay A., Madsen J., McCrae C., Muthas D., Novick S., Ostridge K., Öberg L., Platt A., Postle A.D., Spalluto C.M., Vaarala O., Wang J., Staples K.J., Wilkinson T.M.A.; MICA II Study Group. 2022. Multiomics Links Global Surfactant Dysregulation with Airflow Obstruction and Emphysema in COPD. ERJ Open. Res. 2022 May 15;9(3): 00378–2022. doi: 10.1183/23120541.00378-2022.
Hsieh M.H., Chen P.C., Hsu H.Y., Liu J.C., Ho Y.S., Lin Y.J., Kuo C.W., Kuo W.S., Kao H.F., Wang S.D., Liu Z.G., Wu L.S., Wang J.Y. 2023. Surfactant Protein D Inhibits Lipid-Laden Foamy Macrophages and Lung Inflammation in Chronic Obstructive Pulmonary Disease. Cell. Mol. Immunol. 20(1): 38–50. doi: 10.1038/s41423-022-00946-2
Kahnert K., Jörres R.A., Behr J., Welte T. 2023. The Diagnosis and Treatment of COPD and Its Comorbidities. Dtsch. Arztebl. Int. 120(25): 434–444. doi: 10.3238/arztebl.m2023.027
Khatib S., Sabobeh T., Jaber F., Abdalla K., Singh S., Salzman G. 2022. Use of Laboratory Tests and Their Prognostic Value in Patients with Stable Chronic Obstructive Pulmonary Disease. Mo Med. 119(6): 545–552. PMID: 36588649; PMCID: PMC9762209
Machado F.V.C, Vogelmeier C.F., Jörres R.A., Watz H., Bals R., Welte T., Spruit M.A., Alter P., Franssen F.M.E. 2023. Differential Impact of Low Fat-Free Mass in People with COPD Based on BMI Classifications: Results from the COPD and Systemic Consequences-Comorbidities Network. Chest. 163(5): 1071–1083. doi: 10.1016/j.chest.2022.11.040
Mulas A., Cienfuegos S., Ezpeleta M., Lin S., Pavlou V., Varady K.A. Effect of Intermittent Fasting on Circulating Inflammatory Markers in Obesity: A Review of Human Trials. Front Nutr. 2023 Apr 17;10: 1146924. doi: 10.3389/fnut.2023.1146924
Nandy D., Sharma N., Senapati S. Systematic Review and Meta-Analysis Confirms Significant Contribution of Surfactant Protein D in Chronic Obstructive Pulmonary Disease. Front Genet. 2019;10:339. doi: 10.3389/fgene.2019.00339
Rai M., Parthasarathi A., Beeraka N.M., Kaleem Ullah M., Malamardi S., Padukudru S., Siddaiah J.B., Uthaiah C.A., Vishwanath P., Chaya S.K., Ramaswamy S., Upadhyay S., Ganguly K., Mahesh P.A. 2023. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality. Cells. 12(9): 1281. doi: 10.3390/cells12091281
Yang W., Yang Y., Guo Y., Guo J., Ma M., Han B. Obesity and Risk for Respiratory Diseases: a Mendelian Randomization Study. Front Endocrinol (Lausanne). 2023 Aug 29;14: 1197730. doi: 10.3389/fendo.2023.1197730
The work was carried out without external sources of funding.